Psychedelic therapy: A primer for primary care clinicians - psilocybin
03/23/24 at 03:00 AM
Psychedelic therapy: A primer for primary care clinicians - psilocybin
American Journal of Therapeutics, by Burton J Tabaac, Kenneth Shinozuka, Alejandro Arenas, Bryce D Beutler, Kirsten Cherian, Viviana D Evans, Chelsey Fasano, Owen S Muir; 3/24
Aside from ketamine, psilocybin is the most clinically well-researched psychedelic drug, with trials that have enrolled hundreds of participants and multiple therapeutic applications. Phase III trials will determine whether psilocybin lives up to the promise that it showed in previous clinical trials.